HK Stock MarketDetailed Quotes

08247 BIOSINO BIO-TEC

Watchlist

0.640
-0.010-1.54%

Market Closed Sep 13 16:08 CST

92.61MMarket Cap-4353P/E (TTM)

BIOSINO BIO-TEC Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Assets

Current assets

Inventory

-1.80%63.84M

8.87%60.41M

11.25%65.01M

-7.52%55.49M

-11.51%58.44M

-8.58%60M

-15.69%66.04M

16.02%65.63M

28.41%78.33M

-3.83%56.57M

Accounts receivable

-11.56%177.52M

-16.57%179.8M

-11.59%200.73M

3.89%215.51M

6.84%227.04M

1.40%207.44M

21.17%212.51M

-7.80%204.59M

-13.55%175.38M

56.61%221.89M

Advance deposits and other receivables

-2.30%47.35M

-5.28%46.52M

-30.08%48.47M

-48.93%49.11M

-15.56%69.32M

35.73%96.16M

2.88%82.09M

-7.88%70.85M

165.49%79.79M

-59.76%76.91M

Cash and equivalents

-35.97%35.08M

-18.02%63.41M

51.64%54.78M

73.94%77.35M

58.06%36.12M

-2.16%44.47M

-54.26%22.85M

51.25%45.45M

208.08%49.97M

65.05%30.05M

Secured deposit

----

1,636.81%32.6M

141.26%15.7M

Financial assets at fair value-current assets

----

-71.06%15.52M

49.55%24.45M

Total current assets

-12.25%323.79M

-11.91%350.14M

-5.61%368.99M

-2.60%397.46M

1.94%390.91M

5.58%408.08M

-11.15%383.49M

-9.18%386.52M

-34.08%431.59M

-1.65%425.57M

Non-current assets

Property, plant and equipment

6.27%77.08M

2.08%74.36M

-24.14%72.53M

-23.17%72.84M

-9.60%95.6M

-17.71%94.81M

9.31%105.76M

10.92%115.22M

-7.50%96.75M

-60.71%103.88M

Investment property

-3.43%20.35M

-3.37%20.71M

--21.07M

--21.44M

----

Advance payment

----

0.00%600K

----

0.00%600K

-72.09%600K

-81.08%600K

-32.22%2.15M

Long-term receivables

-81.48%500K

37.06%2.7M

250.65%2.7M

-87.49%1.97M

-95.54%770K

-0.29%15.75M

11.76%17.25M

8.41%15.8M

128.66%15.44M

Associated company interest

17.18%66.5M

22.94%66.5M

16.40%56.75M

13.85%54.09M

4.63%48.76M

2.51%47.51M

5.26%46.6M

-2.71%46.35M

0.95%44.27M

12.03%47.64M

Interests in Joint Venture

2.14%12.24M

-0.52%11.95M

-6.00%11.99M

-5.90%12.02M

-2.26%12.75M

-2.34%12.77M

--13.05M

--13.08M

----

Intangible assets

-3.36%27.88M

0.37%26.54M

0.36%28.85M

-2.70%26.44M

-1.85%28.75M

5.23%27.18M

2.55%29.29M

3.91%25.83M

13.59%28.56M

18.99%24.85M

Goodwill

----

0.00%309K

Deferred tax assets

-95.38%181K

-17.92%3.23M

12.24%3.92M

12.82%3.93M

-8.50%3.49M

-9.00%3.49M

-37.72%3.81M

-37.49%3.83M

47.92%6.12M

47.82%6.13M

Total non-current assets

1.99%212.55M

3.56%213.11M

3.13%208.4M

3.05%205.79M

-11.49%202.08M

-16.13%199.69M

9.91%228.31M

8.52%238.1M

5.49%207.72M

-36.09%219.4M

Total assets

-7.11%536.34M

-6.63%563.25M

-2.63%577.39M

-0.74%603.24M

-3.07%592.99M

-2.70%607.76M

-4.30%611.8M

-3.16%624.61M

-24.93%639.32M

-16.89%644.96M

Liabilities

Current liabilities

Accounts payable

-15.44%108.52M

-18.59%111.54M

-7.34%128.33M

-5.94%137.01M

-5.38%138.5M

16.43%145.67M

50.67%146.38M

5.83%125.12M

-27.82%97.15M

-0.88%118.22M

Tax payable

-3.78%509K

-93.66%220K

-94.19%529K

0.03%3.47M

191.58%9.11M

126.44%3.47M

107.92%3.13M

128.66%1.53M

-70.91%1.5M

-37.62%670K

Other payables and accrued expenses

4.74%60.44M

-8.60%63.01M

-28.15%57.7M

-8.85%68.94M

-3.35%80.3M

-8.12%75.63M

-38.86%83.08M

-41.45%82.32M

-6.57%135.88M

66.74%140.58M

Bank loans and overdrafts

-4.73%136.38M

5.38%140.74M

26.11%143.16M

-17.44%133.55M

-14.92%113.51M

-3.13%161.76M

0.89%133.43M

68.95%166.99M

0.38%132.25M

-40.62%98.84M

Financial lease liabilities-current liabilities

83.83%5.24M

59.40%5.24M

9.15%2.85M

31.21%3.29M

-10.39%2.61M

-14.03%2.51M

-9.25%2.92M

-37.20%2.92M

--3.21M

--4.64M

Total current liabilities

-6.46%311.09M

-7.37%320.75M

-3.34%332.57M

-10.99%346.26M

-6.75%344.04M

2.68%389.03M

-0.29%368.93M

4.38%378.87M

-16.20%370M

-2.20%362.95M

Net current assets

-65.12%12.7M

-42.59%29.39M

-22.30%36.42M

168.81%51.2M

221.95%46.87M

148.95%19.05M

-76.36%14.56M

-87.78%7.65M

-71.11%61.59M

1.62%62.61M

Total assets less current liabilities

-7.99%225.25M

-5.63%242.5M

-1.66%244.82M

17.49%256.98M

2.50%248.95M

-10.99%218.73M

-9.82%242.87M

-12.86%245.75M

-34.33%269.32M

-30.35%282.01M

Non-current liabilities

Long-term bank loan

58.01%4.93M

-73.77%1.98M

-43.57%3.12M

26,857.14%7.55M

-65.31%5.53M

-99.89%28K

-72.28%15.94M

-55.68%24.82M

65.08%57.5M

96.04%56M

Financial lease liabilities-non-current liabilities

-64.86%2.57M

-52.16%3.49M

-21.03%7.3M

-21.02%7.3M

-19.95%9.24M

-8.25%11.55M

-4.60%11.55M

--12.58M

--12.1M

Deferred tax liability

-66.95%2.47M

-22.74%5.56M

-1.50%7.48M

-5.16%7.2M

-18.22%7.59M

-18.25%7.59M

-6.25%9.28M

-6.23%9.29M

48.98%9.9M

73.52%9.9M

Deferred income-non-current liabilities

-97.94%16K

-92.02%66K

-67.76%776K

-66.34%827K

-42.51%2.41M

-27.42%2.46M

-18.59%4.19M

-23.38%3.39M

-30.51%5.14M

-28.45%4.42M

Other non-current liabilities

----

3.85%459K

22.31%444K

--442K

--363K

Special items of non-current liabilities

--2.21M

----

Total non-current liabilities

-34.73%12.19M

-51.47%11.1M

-24.62%18.67M

18.40%22.87M

-40.19%24.77M

-60.96%19.32M

-51.60%41.41M

-40.24%49.48M

75.06%85.57M

104.68%82.79M

Total liabilities

-7.96%323.27M

-10.10%331.85M

-4.76%351.24M

-9.60%369.14M

-10.12%368.81M

-4.67%408.35M

-9.93%410.35M

-3.90%428.34M

-7.10%455.57M

8.31%445.74M

Total assets less total liabilities

-5.79%213.07M

-1.15%231.4M

0.88%226.15M

17.40%234.11M

11.28%224.18M

1.60%199.41M

9.64%201.46M

-1.48%196.27M

-49.13%183.74M

-45.34%199.23M

Total equity and non-current liabilities

-7.99%225.25M

-5.63%242.5M

-1.66%244.82M

17.49%256.98M

2.50%248.95M

-10.99%218.73M

-9.82%242.87M

-12.86%245.75M

-34.33%269.32M

-30.35%282.01M

Equity

Share capital

0.00%144.71M

Reserve

-5.91%52.48M

7.42%65.68M

3.30%55.77M

94.31%61.14M

56.59%53.99M

-3.55%31.47M

98.49%34.48M

8.45%32.63M

-88.22%17.37M

-80.86%30.08M

Shareholders' Equity

-1.65%197.18M

2.20%210.39M

0.90%200.48M

16.84%205.85M

10.89%198.7M

-0.65%176.17M

10.56%179.19M

1.45%177.33M

-44.52%162.08M

-42.10%174.79M

Non-controlling interest

-38.12%15.89M

-25.62%21.02M

0.74%25.67M

21.60%28.26M

14.42%25.48M

22.71%23.24M

2.80%22.27M

-22.49%18.94M

-68.64%21.66M

-60.94%24.43M

Total equity

-5.79%213.07M

-1.15%231.4M

0.88%226.15M

17.40%234.11M

11.28%224.18M

1.60%199.41M

9.64%201.46M

-1.48%196.27M

-49.13%183.74M

-45.34%199.23M

Total equity and total liabilities

-7.11%536.34M

-6.63%563.25M

-2.63%577.39M

-0.74%603.24M

-3.07%592.99M

-2.70%607.76M

-4.30%611.8M

-3.16%624.61M

-24.93%639.32M

-16.89%644.96M

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young Huaming (Special General Partnership), Ernst & Young

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Assets
Current assets
Inventory	-1.80%63.84M	8.87%60.41M	11.25%65.01M	-7.52%55.49M	-11.51%58.44M	-8.58%60M	-15.69%66.04M	16.02%65.63M	28.41%78.33M	-3.83%56.57M
Accounts receivable	-11.56%177.52M	-16.57%179.8M	-11.59%200.73M	3.89%215.51M	6.84%227.04M	1.40%207.44M	21.17%212.51M	-7.80%204.59M	-13.55%175.38M	56.61%221.89M
Advance deposits and other receivables	-2.30%47.35M	-5.28%46.52M	-30.08%48.47M	-48.93%49.11M	-15.56%69.32M	35.73%96.16M	2.88%82.09M	-7.88%70.85M	165.49%79.79M	-59.76%76.91M
Cash and equivalents	-35.97%35.08M	-18.02%63.41M	51.64%54.78M	73.94%77.35M	58.06%36.12M	-2.16%44.47M	-54.26%22.85M	51.25%45.45M	208.08%49.97M	65.05%30.05M
Secured deposit	----	----	----	----	----	----	----	----	1,636.81%32.6M	141.26%15.7M
Financial assets at fair value-current assets	----	----	----	----	----	----	----	----	-71.06%15.52M	49.55%24.45M
Total current assets	-12.25%323.79M	-11.91%350.14M	-5.61%368.99M	-2.60%397.46M	1.94%390.91M	5.58%408.08M	-11.15%383.49M	-9.18%386.52M	-34.08%431.59M	-1.65%425.57M
Non-current assets
Property, plant and equipment	6.27%77.08M	2.08%74.36M	-24.14%72.53M	-23.17%72.84M	-9.60%95.6M	-17.71%94.81M	9.31%105.76M	10.92%115.22M	-7.50%96.75M	-60.71%103.88M
Investment property	-3.43%20.35M	-3.37%20.71M	--21.07M	--21.44M	----	----	----	----	----	----
Advance payment	----	----	0.00%600K	----	0.00%600K	0.00%600K	0.00%600K	-72.09%600K	-81.08%600K	-32.22%2.15M
Long-term receivables	-81.48%500K	-81.48%500K	37.06%2.7M	250.65%2.7M	-87.49%1.97M	-95.54%770K	-0.29%15.75M	11.76%17.25M	8.41%15.8M	128.66%15.44M
Associated company interest	17.18%66.5M	22.94%66.5M	16.40%56.75M	13.85%54.09M	4.63%48.76M	2.51%47.51M	5.26%46.6M	-2.71%46.35M	0.95%44.27M	12.03%47.64M
Interests in Joint Venture	2.14%12.24M	-0.52%11.95M	-6.00%11.99M	-5.90%12.02M	-2.26%12.75M	-2.34%12.77M	--13.05M	--13.08M	----	----
Intangible assets	-3.36%27.88M	0.37%26.54M	0.36%28.85M	-2.70%26.44M	-1.85%28.75M	5.23%27.18M	2.55%29.29M	3.91%25.83M	13.59%28.56M	18.99%24.85M
Goodwill	----	----	----	----	----	----	0.00%309K	0.00%309K	0.00%309K	0.00%309K
Deferred tax assets	-95.38%181K	-17.92%3.23M	12.24%3.92M	12.82%3.93M	-8.50%3.49M	-9.00%3.49M	-37.72%3.81M	-37.49%3.83M	47.92%6.12M	47.82%6.13M
Total non-current assets	1.99%212.55M	3.56%213.11M	3.13%208.4M	3.05%205.79M	-11.49%202.08M	-16.13%199.69M	9.91%228.31M	8.52%238.1M	5.49%207.72M	-36.09%219.4M
Total assets	-7.11%536.34M	-6.63%563.25M	-2.63%577.39M	-0.74%603.24M	-3.07%592.99M	-2.70%607.76M	-4.30%611.8M	-3.16%624.61M	-24.93%639.32M	-16.89%644.96M
Liabilities
Current liabilities
Accounts payable	-15.44%108.52M	-18.59%111.54M	-7.34%128.33M	-5.94%137.01M	-5.38%138.5M	16.43%145.67M	50.67%146.38M	5.83%125.12M	-27.82%97.15M	-0.88%118.22M
Tax payable	-3.78%509K	-93.66%220K	-94.19%529K	0.03%3.47M	191.58%9.11M	126.44%3.47M	107.92%3.13M	128.66%1.53M	-70.91%1.5M	-37.62%670K
Other payables and accrued expenses	4.74%60.44M	-8.60%63.01M	-28.15%57.7M	-8.85%68.94M	-3.35%80.3M	-8.12%75.63M	-38.86%83.08M	-41.45%82.32M	-6.57%135.88M	66.74%140.58M
Bank loans and overdrafts	-4.73%136.38M	5.38%140.74M	26.11%143.16M	-17.44%133.55M	-14.92%113.51M	-3.13%161.76M	0.89%133.43M	68.95%166.99M	0.38%132.25M	-40.62%98.84M
Financial lease liabilities-current liabilities	83.83%5.24M	59.40%5.24M	9.15%2.85M	31.21%3.29M	-10.39%2.61M	-14.03%2.51M	-9.25%2.92M	-37.20%2.92M	--3.21M	--4.64M
Total current liabilities	-6.46%311.09M	-7.37%320.75M	-3.34%332.57M	-10.99%346.26M	-6.75%344.04M	2.68%389.03M	-0.29%368.93M	4.38%378.87M	-16.20%370M	-2.20%362.95M
Net current assets	-65.12%12.7M	-42.59%29.39M	-22.30%36.42M	168.81%51.2M	221.95%46.87M	148.95%19.05M	-76.36%14.56M	-87.78%7.65M	-71.11%61.59M	1.62%62.61M
Total assets less current liabilities	-7.99%225.25M	-5.63%242.5M	-1.66%244.82M	17.49%256.98M	2.50%248.95M	-10.99%218.73M	-9.82%242.87M	-12.86%245.75M	-34.33%269.32M	-30.35%282.01M
Non-current liabilities
Long-term bank loan	58.01%4.93M	-73.77%1.98M	-43.57%3.12M	26,857.14%7.55M	-65.31%5.53M	-99.89%28K	-72.28%15.94M	-55.68%24.82M	65.08%57.5M	96.04%56M
Financial lease liabilities-non-current liabilities	-64.86%2.57M	-52.16%3.49M	-21.03%7.3M	-21.02%7.3M	-19.95%9.24M	-19.95%9.24M	-8.25%11.55M	-4.60%11.55M	--12.58M	--12.1M
Deferred tax liability	-66.95%2.47M	-22.74%5.56M	-1.50%7.48M	-5.16%7.2M	-18.22%7.59M	-18.25%7.59M	-6.25%9.28M	-6.23%9.29M	48.98%9.9M	73.52%9.9M
Deferred income-non-current liabilities	-97.94%16K	-92.02%66K	-67.76%776K	-66.34%827K	-42.51%2.41M	-27.42%2.46M	-18.59%4.19M	-23.38%3.39M	-30.51%5.14M	-28.45%4.42M
Other non-current liabilities	----	----	----	----	----	----	3.85%459K	22.31%444K	--442K	--363K
Special items of non-current liabilities	--2.21M	----	----	----	----	----	----	----	----	----
Total non-current liabilities	-34.73%12.19M	-51.47%11.1M	-24.62%18.67M	18.40%22.87M	-40.19%24.77M	-60.96%19.32M	-51.60%41.41M	-40.24%49.48M	75.06%85.57M	104.68%82.79M
Total liabilities	-7.96%323.27M	-10.10%331.85M	-4.76%351.24M	-9.60%369.14M	-10.12%368.81M	-4.67%408.35M	-9.93%410.35M	-3.90%428.34M	-7.10%455.57M	8.31%445.74M
Total assets less total liabilities	-5.79%213.07M	-1.15%231.4M	0.88%226.15M	17.40%234.11M	11.28%224.18M	1.60%199.41M	9.64%201.46M	-1.48%196.27M	-49.13%183.74M	-45.34%199.23M
Total equity and non-current liabilities	-7.99%225.25M	-5.63%242.5M	-1.66%244.82M	17.49%256.98M	2.50%248.95M	-10.99%218.73M	-9.82%242.87M	-12.86%245.75M	-34.33%269.32M	-30.35%282.01M
Equity
Share capital	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M	0.00%144.71M
Reserve	-5.91%52.48M	7.42%65.68M	3.30%55.77M	94.31%61.14M	56.59%53.99M	-3.55%31.47M	98.49%34.48M	8.45%32.63M	-88.22%17.37M	-80.86%30.08M
Shareholders' Equity	-1.65%197.18M	2.20%210.39M	0.90%200.48M	16.84%205.85M	10.89%198.7M	-0.65%176.17M	10.56%179.19M	1.45%177.33M	-44.52%162.08M	-42.10%174.79M
Non-controlling interest	-38.12%15.89M	-25.62%21.02M	0.74%25.67M	21.60%28.26M	14.42%25.48M	22.71%23.24M	2.80%22.27M	-22.49%18.94M	-68.64%21.66M	-60.94%24.43M
Total equity	-5.79%213.07M	-1.15%231.4M	0.88%226.15M	17.40%234.11M	11.28%224.18M	1.60%199.41M	9.64%201.46M	-1.48%196.27M	-49.13%183.74M	-45.34%199.23M
Total equity and total liabilities	-7.11%536.34M	-6.63%563.25M	-2.63%577.39M	-0.74%603.24M	-3.07%592.99M	-2.70%607.76M	-4.30%611.8M	-3.16%624.61M	-24.93%639.32M	-16.89%644.96M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Ernst & Young Huaming (Special General Partnership), Ernst & Young	--	Ernst & Young Huaming (Special General Partnership), Ernst & Young	--	Ernst & Young Huaming (Special General Partnership), Ernst & Young	--	Ernst & Young Huaming (Special General Partnership), Ernst & Young	--	Ernst & Young Huaming (Special General Partnership), Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

08247 BIOSINO BIO-TEC

BIOSINO BIO-TEC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target